Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

KyungAh Im

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Journal of the American Heart Association|August 23, 2021
Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 TrialBrian A Bergmark, Deepak L Bhatt, P Gabriel Steg, et al.
European Heart Journal|October 23, 2015
Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54Marc P Bonaca, Deepak L Bhatt, P Gabriel Steg, et al.
Circulation|December 28, 2018
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular RiskMichelle L O'Donoghue, Sergio Fazio, Robert P Giugliano, et al.
JAMA Cardiology|July 21, 2016
Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events: A Secondary Analysis of the PEGASUS-TIMI 54 TrialMarc P Bonaca, Deepak L Bhatt, Ton Oude Ophuis, et al.
Journal of the American College of Cardiology|February 7, 2018
Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary DiseaseSameer Bansilal, Marc P Bonaca, Jan H Cornel, et al.
The New England Journal of Medicine|June 4, 2015
Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesChristopher P Cannon, Michael A Blazing, Robert P Giugliano, et al.
JAMA|September 1, 2014
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trialMichelle L O'Donoghue, Eugene Braunwald, Harvey D White, et al.
The New England Journal of Medicine|March 17, 2015
Long-term use of ticagrelor in patients with prior myocardial infarctionMarc P Bonaca, Deepak L Bhatt, Marc Cohen, et al.
Journal of the American Heart Association|December 21, 2018
Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54Marc P Bonaca, Stephen D Wiviott, David A Morrow, et al.
The New England Journal of Medicine|August 28, 2018
Cardiovascular Safety of Lorcaserin in Overweight or Obese PatientsErin A Bohula, Stephen D Wiviott, Darren K McGuire, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Journal of the American Heart Association|August 23, 2021
Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 TrialBrian A Bergmark, Deepak L Bhatt, P Gabriel Steg, et al.
European Heart Journal|October 23, 2015
Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54Marc P Bonaca, Deepak L Bhatt, P Gabriel Steg, et al.
Circulation|December 28, 2018
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular RiskMichelle L O'Donoghue, Sergio Fazio, Robert P Giugliano, et al.
JAMA Cardiology|July 21, 2016
Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events: A Secondary Analysis of the PEGASUS-TIMI 54 TrialMarc P Bonaca, Deepak L Bhatt, Ton Oude Ophuis, et al.
Journal of the American College of Cardiology|February 7, 2018
Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary DiseaseSameer Bansilal, Marc P Bonaca, Jan H Cornel, et al.
The New England Journal of Medicine|June 4, 2015
Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesChristopher P Cannon, Michael A Blazing, Robert P Giugliano, et al.
JAMA|September 1, 2014
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trialMichelle L O'Donoghue, Eugene Braunwald, Harvey D White, et al.
The New England Journal of Medicine|March 17, 2015
Long-term use of ticagrelor in patients with prior myocardial infarctionMarc P Bonaca, Deepak L Bhatt, Marc Cohen, et al.
Journal of the American Heart Association|December 21, 2018
Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54Marc P Bonaca, Stephen D Wiviott, David A Morrow, et al.
The New England Journal of Medicine|August 28, 2018
Cardiovascular Safety of Lorcaserin in Overweight or Obese PatientsErin A Bohula, Stephen D Wiviott, Darren K McGuire, et al.
Pageof 8